To examine whether the E3 ubiquitin ligase activity of RNF39 contributes to its tumour‐promoting effects, RNF39 knockout (RNF39−/−) HCT116 and SW480 cells were generated using CRISPR‐Cas9 genome editing. The gene discussed is RNF39; the disease is neoplasm.